Genetic testing in aortic aneurysm disease: PRO
- PMID: 20452526
- PMCID: PMC3615454
- DOI: 10.1016/j.ccl.2010.01.017
Genetic testing in aortic aneurysm disease: PRO
Abstract
Thoracic aortic aneurysms leading to type A dissections (TAAD) are the major diseases affecting the aorta. A genetic predisposition for TAAD can occur as part of a genetic syndrome. It can be inherited in an autosomal dominant manner with decreased penetrance and variable expression. Genetic heterogeneity for familial TAAD has been demonstrated with the identification of four genes leading to TAAD. Genetic testing for TAAD and the phenotype and management of patients harboring mutations in these genes are addressed in this article.
Copyright 2010 Elsevier Inc. All rights reserved.
Comment in
- 
  
  Genetic testing in aortic aneurysm disease: CON.Cardiol Clin. 2010 May;28(2):199-204. doi: 10.1016/j.ccl.2010.02.002. Cardiol Clin. 2010. PMID: 20452527 Review.
- 
  
  Editorial comment: genetic testing in aortic aneurysm disease.Cardiol Clin. 2010 May;28(2):205-6. doi: 10.1016/j.ccl.2010.02.007. Cardiol Clin. 2010. PMID: 20452528 No abstract available.
References
- 
    - Milewicz DM, Dietz HC, Miller DC. Treatment of aortic disease in patients with Marfan syndrome. Circulation. 2005;111:e150–e157. - PubMed
 
- 
    - Finkbohner R, Johnston D, Crawford ES, Coselli J, Milewicz DM. Marfan syndrome. Long-term survival and complications after aortic aneurysm repair. Circulation. 1995;91:728–733. - PubMed
 
- 
    - Silverman DI, Gray J, Roman MJ, et al. Family history of severe cardiovascular disease in Marfan syndrome is associated with increased aortic diameter and decreased survival. J Am Coll Cardiol. 1995;26:1062–1067. - PubMed
 
- 
    - Silverman DI, Burton KJ, Gray J, et al. Life expectancy in the Marfan syndrome. Am J Cardiol. 1995;75:157–160. - PubMed
 
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
- Full Text Sources
- Medical
 
        